HTD1801 (Berberine Ursodeoxycholate)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HTD1801 (Berberine Ursodeoxycholate), covering 2024-05-13 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes [Phase 3]